Abstract
Multidrug resistance (MDR), a major cause for chemotherapy failure, has been linked to upregulation of ATP-dependent membrane efflux systems that limit intracellular accumulation of cytotoxic anticancer agents. P-glycoprotein (P-gp) encoded by the human ABCB1 gene was the first efflux transporter identified to contribute to MDR. ABCB1 gene expression is correlated with constitutive activation of the NF-κB signaling pathway in tumor cells. The objective of this research is to modulate P-gp activity in colon cancer cells using NF-κB decoy oligodeoxynucleotides (ODNs) that are effectively delivered into the nucleus of colorectal cancer cells by self-assembling nonviral nanoparticles comprising the novel poly[N-(2-hydroxypropyl)methacrylamide]-poly(N,N-dimethylaminoethylmethacrylate) diblock copolymer (pHPMA-b-pDMAEMA). Ethidium bromide intercalation and gel retardation assays demonstrated high DNA condensation capacity of pHPMA-b-pDMAEMA. Nanoparticles prepared with and without decoy ODNs did not significantly compromise cellular safety at N/P ratios ⩽4. Transfection efficiency of pHPMA-b-pDMAEMA polyplexes (N/P=4) in Caco-2 cells was comparable to TurboFect transfection standard, resulting in a 98% reduction in P-gp protein levels. As a pharmacodynamic consequence, intracellular accumulation of the P-gp substrate Rhodamine123 significantly increased by almost twofold. In conclusion, NF-κB ODN polyplexes fabricated with pHPMA-b-pDMAEMA polymer effectively reduced P-gp-mediated efflux activity in Caco-2 cells, suggesting successful interference with NF-κB-binding sites in the promoter region of the ABCB1 gene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Linn SC, Giaccone G . MDR1/P-glycoprotein expression in colorectal cancer. Eur J Cancer 1995; 31A: 1291–1294.
Gottesman MM, Fojo T, Bates SE . Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002; 2: 48–58.
Ashkenazi A, Dixit VM . Death receptors: signaling and modulation. Science 1998; 281: 1305–1308.
Haddad JJ, Abdel-Karim NE . NF-kappaB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation? Cell Immunol 2011; 271: 5–14.
Zhang J, Lu M, Zhou F, Sun H, Hao G, Wu X et al. Key role of nuclear factor-kappaB in the cellular pharmacokinetics of adriamycin in MCF-7/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2. Drug Metab Dispos 2012; 40: 1900–1908.
Escarcega RO, Fuentes-Alexandro S, Garcia-Carrasco M, Gatica A, Zamora A . The transcription factor nuclear factor-kappa B and cancer. Clin Oncol (R Coll Radiol) 2007; 19: 154–161.
Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997; 3: 894–899.
Agrawal S, Temsamani J, Tang JY . Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice. Proc Natl Acad Sci USA 1991; 88: 7595–7599.
Akhtar S, Kole R, Juliano RL . Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci 1991; 49: 1793–1801.
De Rosa G, Quaglia F, Bochot A, Ungaro F, Fattal E . Long-term release and improved intracellular penetration of oligonucleotide-polyethylenimine complexes entrapped in biodegradable microspheres. Biomacromolecules 2003; 4: 529–536.
Godbey WT, Wu KK, Mikos AG . Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 1999; 96: 5177–5181.
Merdan T, Kopecek J, Kissel T . Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug Deliv Rev 2002; 54: 715–758.
Oupicky D, Howard KA, Konak C, Dash PR, Ulbrich K, Seymour LW . Steric stabilization of poly-L-Lysine/DNA complexes by the covalent attachment of semitelechelic poly[N-(2-hydroxypropyl)methacrylamide]. Bioconjug Chem 2000; 11: 492–501.
Palermo EF, Lee DK, Ramamoorthy A, Kuroda K . Role of cationic group structure in membrane binding and disruption by amphiphilic copolymers. J Phys Chem B 2011; 115: 366–375.
Duvall CL, Convertine AJ, Benoit DS, Hoffman AS, Stayton PS . Intracellular delivery of a proapoptotic peptide via conjugation to a RAFT synthesized endosomolytic polymer. Mol Pharm 2010; 7: 468–476.
Xing Y, Yang Y, Zhou F, Wang J . Characterization of genome-wide binding of NF-kappaB in TNFalpha-stimulated HeLa cells. Gene 2013; 526: 142–149.
Nakahara C, Nakamura K, Yamanaka N, Baba E, Wada M, Matsunaga H et al. Cyclosporin-A enhances docetaxel-induced apoptosis through inhibition of nuclear factor-kappaB activation in human gastric carcinoma cells. Clin Cancer Res 2003; 9: 5409–5416.
Fang Y, Sun H, Zhai J, Zhang Y, Yi S, Hao G et al. Antitumor activity of NF-kB decoy oligodeoxynucleotides in a prostate cancer cell line. Asian Pacific J Cancer Prev 2011; 12: 2721–2726.
Dixit SG, Zingarelli B, Buckley DJ, Buckley AR, Pauletti GM . Nitric oxide mediates increased P-glycoprotein activity in interferon-{gamma}-stimulated human intestinal cells. Am J Physiol Gastrointest Liver Physiol 2005; 288: G533–G540.
Burke RS, Pun SH . Extracellular barriers to in vivo PEI and PEGylated PEI polyplex-mediated gene delivery to the liver. Bioconjug Chem 2008; 19: 693–704.
Goyal R, Tripathi SK, Tyagi S, Ram KR, Ansari KM, Kumar P et al. Gellan gum-PEI nanocomposites as efficient gene delivery agents. J Biomed Nanotechnol 2011; 7: 38–39.
Benns JM, Choi JS, Mahato RI, Park JS, Kim SW . pH-sensitive cationic polymer gene delivery vehicle: N-Ac-poly(L-histidine)-graft-poly(L-lysine) comb shaped polymer. Bioconjug Chem 2000; 11: 637–645.
Rungsardthong U, Ehtezazi T, Bailey L, Armes SP, Garnett MC, Stolnik S . Effect of polymer ionization on the interaction with DNA in nonviral gene delivery systems. Biomacromolecules 2003; 4: 683–690.
Zaghloul EM, Viola JR, Zuber G, Smith CI, Lundin KE . Formulation and delivery of splice-correction antisense oligonucleotides by amino acid modified polyethylenimine. Mol Pharm 2010; 7: 652–663.
Zeng X, Pan S, Li J, Wang C, Wen Y, Wu H et al. A novel dendrimer based on poly (L-glutamic acid) derivatives as an efficient and biocompatible gene delivery vector. Nanotechnology 2011; 22: 375102.
Je JY, Cho YS, Kim SK . Characterization of (aminoethyl)chitin/DNA nanoparticle for gene delivery. Biomacromolecules 2006; 7: 3448–3451.
van de Wetering P, Cherng J-Y, Talsma H, Hennink WE . Relation between transfection efficiency and cytotoxicity of poly(2-(dimethylamino)ethyl methacrylate)/plasmid complexes. J Control Release 1997; 49: 59–69.
Kao CY, Yang SJ, Tao MH, Jeng YM, Yu IS, Lin SW . Incorporation of the factor IX Padua mutation into FIX-Triple improves clotting activity in vitro and in vivo. Thromb Haemost 2013; 110: 244–256.
Barner-Kowollik C . Handbook of RAFT polymerization, 2008.
De Rosa G, Maiuri MC, Ungaro F, De Stefano D, Quaglia F, La Rotonda MI et al. Enhanced intracellular uptake and inhibition of NF-kappaB activation by decoy oligonucleotide released from PLGA microspheres. J Gene Med 2005; 7: 771–781.
de Martimprey H, Vauthier C, Malvy C, Couvreur P . Polymer nanocarriers for the delivery of small fragments of nucleic acids: oligonucleotides and siRNA. Eur J Pharm Biopharm 2009; 71: 490–504.
Lu B, Xu XD, Zhang XZ, Cheng SX, Zhuo RX . Low molecular weight polyethylenimine grafted N-maleated chitosan for gene delivery: properties and in vitro transfection studies. Biomacromolecules 2008; 9: 2594–2600.
Sun J, Yeung CA, Co NN, Tsang TY, Yau E, Luo K et al. Clitocine reversal of P-glycoprotein associated multi-drug resistance through down-regulation of transcription factor NF-kappaB in R-HepG2 cell line. PLoS One 2012; 7: e40720.
Chaudhary PM, Roninson IB . Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991; 66: 85–94.
Chaudhary PM, Roninson IB . Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 1993; 85: 632–639.
Kim HG, Hien TT, Han EH, Hwang YP, Choi JH, Kang KW et al. Metformin inhibits P-glycoprotein expression via the NF-kappaB pathway and CRE transcriptional activity through AMPK activation. Br J Pharmacol 2011; 162: 1096–1108.
Quesada AR, Barbacid MM, Mira E, Aracil M, Marquez G . Chemosensitization and drug accumulation assays as complementary methods for the screening of multidrug resistance reversal agents. Cancer Lett 1996; 99: 109–114.
Buyens K, Lucas B, Raemdonck K, Braeckmans K, Vercammen J, Hendrix J et al. A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. J Control Release 2008; 126: 67–76.
Acknowledgements
This research was supported in part by a predoctoral fellowship from the Egyptian Ministry of Higher Education awarded to Noura H Abd Ellah.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Abd Ellah, N., Taylor, L., Ayres, N. et al. NF-κB decoy polyplexes decrease P-glycoprotein-mediated multidrug resistance in colorectal cancer cells. Cancer Gene Ther 23, 149–155 (2016). https://doi.org/10.1038/cgt.2016.17
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2016.17
This article is cited by
-
Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity
BMC Pharmacology and Toxicology (2023)